01712nam 2200397 450 991063396950332120230326171550.01-83969-967-1(CKB)5700000000338666(NjHacI)995700000000338666(EXLCZ)99570000000033866620230326d2022 uy 0engur|||||||||||txtrdacontentcrdamediacrrdacarrierNew knowledge about pulmonary thromboembolism /edited by Jelena StojšicLondon :IntechOpen,[2022]©20221 online resource (86 pages)1-83969-966-3 1. Introductory Chapter: Pulmonary Embolism. 2. Diagnosis of Pulmonary Embolism. 3. Pulmonary Embolism in COVID-19 Patients: Facts and Figures. 4. Anticoagulants in the Management of Pulmonary Embolism. 5. Thrombolytic Therapy in Pulmonary Thromboembolism.Thromboembolism is the most common cause of death in autopsied patients. Recently, this disorder has become a topic of interest due to it being a frequent complication of COVID-19 infection. This book discusses pulmonary thromboembolism in COVID-19 and non-COVID-19 patients, such as those with malignancies such as paraneoplastic symptoms or heart and lung diseases.Pulmonary embolismThromboembolismPulmonary embolism.Thromboembolism.616.249Stojšic JelenaNjHacINjHaclBOOK9910633969503321New knowledge about pulmonary thromboembolism3086751UNINA